Creeping Eruption: A Review of Clinical Presentation and Management of 60 Cases Presenting to a Tropical Disease Unit

Archives of Dermatology

Volumn 129, Issue 5, 1993, Pages 588-591

  Davies, Herbert D ^a   Sakuls, Peter ^b   Keystone, Jay S ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Toronto Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; LIQUID NITROGEN; TIABENDAZOLE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL FEATURE; DIAGNOSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; ETIOLOGY; FEMALE; HOOKWORM; HUMAN; LARVA MIGRANS; MAJOR CLINICAL STUDY; MALE; NEMATODE; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TROPICAL DISEASE; VOMITING;

ADOLESCENT; ADULT; AGED; ALBENDAZOLE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; LARVA MIGRANS; MALE; MIDDLE AGE; THIABENDAZOLE;

EID: 85047690521     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.129.5.588     Document Type: Article

References (33)

1. Katz M, Despommier D, Gwadz R. Parasitic Diseases. 2nd ed. New York, NY: Springler-Verlag NY Inc; 1988: 301.
2. Nash T. Visceral larva migrans and other unusual helminth infections. In: Mandell G, Douglas R, Bennett J, ed. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone Inc; 1990: 2340.
3. Bedi B, Shetty A. Larva migrans. Indian J Dermatol. 1974; 19: 64-66.
4. Katz R, Ziegler J, Blank H. The natural course of creeping eruption and treatment with thiabendazole. Arch Dermatol. 1965; 91: 420.
5. Davis C, Israel R. Treatment of creeping eruption with topical thiabendazole. Arch Dermatol. 1968; 97: 325.
6. Sperber P. Treatment of creeping eruption with orally and topically administered thiabendazole. J Florida Med Assoc. 1967; 54: 1059-1061.
7. Eyster WJ. Local thiabendazole in the treatment of creeping eruption. Arch Dermatol. 1967; 95: 620-621.
8. Battistini F. Treatment of creeping eruption with topical thiabendazole. Texas Rep Biol Med. 1969; 27(suppl 2): 645.
9. Evaluation of a broad-spectrum antihelminthic thiabendazole (Mintezol). JAMA. 1968; 205: 172-173.
10. Hardin TJ. Management of cutaneous larva migrans in pediatric practice: report on 200 cases. J Am Osteopath Assoc. 1969; 68: 970-972.
11. Katz R, Hood R. Topical thiabendazole for creeping eruption. Arch Dermatol. 1966; 94: 643-645.
12. Katz R, Hood R. The use of topical thiabendazole in dimethylsulfoxide for creeping eruption: a preliminary report. J Invest Dermatol. 1966; 46: 309-310.
13. Canizares O. Larval migrans. In: Clinical Tropical Dermatology. Boston, Mass: Blackwell Scientific Publications Inc; 1975: 210-211.
14. Herbener D, Borak J. Cutaneous larva migrans in northern climates. Am J Emerg Med. 1988; 6: 462-464.
15. Elliot D, Tolle S, Goldberg L, et al. Pet-associated illnesses. N Engl J Med. 1985; 313: 985-995.
16. Edelglass J, Douglass M, Stiefler R, Tessler M. Cutaneous larva migrans in northern climates: a souvenir of your dream vacation. J Am Acad Dermatol. 1982; 7: 353-358.
17. Allen C. Cutaneous larva migrans: a traveller's disease. N Z Med J. 1990; 103: 345.
18. Wright D, Gold E. Löffler's syndrome associated with creeping eruption (cutaneous helminthiasis). Arch Intern Med. 1946; 78: 303.
19. Guill M, Odom R. Larva migrans complicated by Löffler's syndrome. Arch Dermatol. 1978; 114: 1525-1526.
20. Ambrus J, Klein E. Loffler syndrome and ancylostomiasis brasiliensis. N Y State J Med. 1988; 88: 498-499.
21. Pinkus H, Fan J, DeGiusti D. Creeping eruption due to Gnathostoma spinigerum in a Taiwanese patient. Int J Dermatol. 1981; 20: 46-49.
22. Jones C, Rosen T, Greenberg C. Cutaneous larva migrans due to Pelodera strongyloides. Cutis. 1991; 48: 123-126.
23. Stone O, Newell G, Mullins J. Cutaneous strongyloidiasis: larva curens. Arch Dermatol. 1972; 106: 734.
24. Whiting D. The successful treatment of creeping eruption with topical thiabendazole. S Afr Med J. 1976; 50: 253-255.
25. Goldsmith J, Froese E. A note on cutaneous larva migrans and its treatment with topical thiabendazole. Cent Afr J Med. 1977; 23: 250-251.
26. Burry J. No dogs on beaches, please. Med J Aust. 1978; 1: 40.
27. Stone O, Mullins J. Thiabendazole effectiveness in creeping eruption. Arch Dermatol. 1965; 91: 427-429.
28. Torres J, Orihuela A, Garcia D, Abdul-Hadi S. Treatment of cutaneous larva migrans with albendazole: preliminary report. Rev Inst Med Trop Sao Paulo. 1989; 31: 56-58.
29. Williams H, Monk B. Creeping eruption stopped in its tracks by albendazole. Clin Exp Dermatol. 1989; 14: 355-356.
30. Jones S, Reynolds N, Oliwiecki S, Harman R. Oral albendazole for the treatment of cutaneous larva migrans. Br J Dermatol. 1990; 122: 99-101.
31. Sanguigni S, Marangi M, Teggi A, De Rosa F. Albendazole in the therapy of cutaneous larva migrans. Trans R Soc Trop Med Hyg. 1990; 84: 83.
32. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs. 1991; 42: 640-658.
33. Caumes E, Datry A, Paris L, Danis M, Gentilini M, Gaxotte P. Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol. 1992; 128: 994-945.